Access to Xeomin expanded in the USA . . .

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.624, 2011-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Global access to HIV/AIDS drugs expanded with new alliance . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®

By Frevert Jürgen  

Drugs in R&D, Vol. 10, Iss. 2, 2010-07 ,pp. : 67-73

Adis International

Access to resources Recommend Favorite

Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN ® ) in Focal Dystonia

By Jost Wolfgang H.  

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 669-683

Adis International

Access to resources Recommend Favorite

Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA

By Deren S.   Fuller C.   Pouget E.R.   Blaney S.   Tortu S.   Kang S.-Y.   McMahon J.M.   Andia J.F.   Des Jarlais D.C.   Johnson B.   Rosenblum A.   Vlahov D.  

The International Journal of Drug Policy, Vol. 14, Iss. 5, 2003-12 ,pp. : 373-379

Elsevier

Access to resources Recommend Favorite

Expanded role for Pharmac

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite